YSLab
6
0
0
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 6 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Clinical Evaluation of the Efficacy of a Nasal Spray in the Treatment of Nasal Dryness
Role: lead
Evaluation of a Medical Device Based on Isotonic Seawater and Hyaluronic Acid Used as a Nasal Spray
Role: lead
Safety and Effectiveness of an Auricular Spray
Role: lead
Usage Test on a New Cosmetic Product: Mouthwash
Role: lead
Efficacy of Two Nasal Products Based on Diluted Seawater in the Treatment of Upper Respiratory Infections/Conditions
Role: lead
Efficacy of Two Nasal Products for Decongestion and Mucus Fluidification
Role: lead
All 6 trials loaded